A kindred with a variant of multiple endocrine neoplasia type 1 demonstrating frequent expression of pituitary tumors but not linked to the multiple endocrine neoplasia type 1 locus at chromosome region 11q13

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 2, 1997, Pages 486-492

  Stock, John L ^a,b,i   Warth, Maria R ^c   Teh, Bin Tean ^d   Coderre, James A ^a   Overdorf, Judith H ^a   Baumann, Gerhard ^e   Hintz, Raymond L ^f   Hartman, Mark L ^g   Seizinger, Bernd R ^h,j   Larsson, Catharina ^d   Aronin, Neil ^b  

^a Endocrinology Laboratory   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e NORTHWESTERN UNIVERSITY   (United States)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^h MASSACHUSETTS GENERAL HOSPITAL   (United States)

ⁱ Memorial Health Care   (United States)

^j BRISTOL MYERS SQUIBB   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACROMEGALY; ADULT; AGED; ARTICLE; CHROMOSOME 11Q; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; FEMALE; GENE LOCATION; HETEROZYGOTE DETECTION; HUMAN; HYPOPHYSIS TUMOR; MALE; MULTIPLE ENDOCRINE NEOPLASIA; PEDIGREE ANALYSIS; PENETRANCE; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL;

ACROMEGALY; AGED; AGED, 80 AND OVER; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 11; FEMALE; HUMANS; LINKAGE (GENETICS); MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; PEDIGREE; PITUITARY NEOPLASMS;

EID: 8044258981     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.2.486     Document Type: Article

References (61)

1. Brandi ML, Marx SJ, Aurbach GD, Fitzpatrick LA. 1987 Familial multiple endocrine neoplasia type I: a new look at pathophysiology. Endocr Rev. 8:391-405.
2. Larsson C, Skogseid B, Oberg K, Nakamura Y, Nordenskjold M. 1988 Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature. 332:85-87.
3. Bystrom C, Larsson C, Blomberg C, et al. 1990 Localization of the MEN1 gene to a small region within chromosome 11q13 by deletion mapping in tumors. Proc Natl Acad Sci USA. 87:1968-1972.
4. Thakker RV, Wooding C, Pang JT, et al. 1993 Linkage analysis of 7 polymorphic markers at chromosome 11p11.2-11q13 in 27 multiple endocrine neoplasia type 1 families. Ann Hum Genet. 57:17-25.
5. Larsson C, Friedman E. 1994 Localization and identification of the multiple endocrine neoplasia type 1 disease gene. Endocrinol Metab Clin North Am. 23:67-79.
6. Weber G, Friedman E, Grimmond S, et al. 1994 The phospholipase Cβ3 gene located in the MEN1 region shows loss of expression in endocrine tumors. Hum Mol Genet. 3:1775-1781.
7. Larsson C, Calender A, Grimmond S, et al. 1995 Molecular tools for presymptomatic testing in multiple endocrine neoplasia type 1. J Intern Med. 238:239-244.
8. Friedman E, Larsson C, Amorosi A, et al. 1994 Multiple endocrine neoplasia type 1: pathology, pathophysiology, molecular genetics, and differential diagnosis. In: Bilezikian JP, Marcus R, Levine MA, eds. The parathyroids: basic and clinical concepts. New York: Raven Press; 647-680.
9. Marx SJ, Vinik AI, Santen RJ, Floyd Jr JC, Mills JL, Green III J. 1986 Multiple endocrine neoplasia type I: assessment of laboratory tests to screen for the gene in a large kindred. Medicine. 65:226-241.
10. Stock JL, Coderre JA, Mallette LE. 1985 Effects of a short course of estrogen on mineral metabolism in postmenopausal women. J Clin Endocrinol Metab. 61:595-600.
11. Furlanetto RW, Underwood LE, Van Wyk JJ, D'Ercole AJ. 1977 Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay. J Clin Invest. 60:648-657.
12. Liu F, Powell DR, Styne DM, Hintz RL. 1991 Insulin-like growth factor and insulin-like growth factor binding proteins in the developing rhesus monkey. J Clin Endocrinol Metab. 72:905-911.
13. Giudice LC, Farrell EM, Pham H, Lamson G, Rosenfeld RG. 1990 Insulin-like growth factor binding proteins in maternal serum throughout gestation and in the peurperium: effects of a pregnancy-associated serum protease activity. J Clin Endocrinol Metab. 71:806-816.
14. Baumann G, Shaw MA, Amburn K. 1989 Regulation of plasma growth hormone-binding proteins in health and disease. Metabolism. 38:683-689.
15. Vale W, Vaughan J, Jolley D, et al. 1986 Assay of growth hormone-releasing factor. Methods Enzymol. 124:389-401.
16. Veldhuis JD, Johnson ML. 1986 Cluster analysis: a simple, versatile, and robust algorithm for endocrine pulse detection. Am J Physiol. 250:E486-E493.
17. Hartman ML, Veldhuis JD, Vance ML, Faria ACS, Furlanetto RW, Thorner MO. 1990 Somatotropin pulse frequency and basal concentrations are increased in acromegaly and are reduced by successful therapy. J Clin Endocrinol Metab. 70:1375-1384.
18. Teh BT, Cardinal J, Shepherd J, et al. 1995 Genetic mapping of the multiple endocrine neoplasia type 1 locus at 11q13. J Intern Med. 238:249-253.
19. Teh BT, McArdle J, Parameswaran V, et al. Sporadic hyperparathyroidism in the setting of multiple endocrine neoplasia type 1. Arch Surg. 131:1230-1232.
20. Metz DC, Jensen RT, Bale AE, et al. 1994 Multiple endocrine neoplasia type I: clinical features and management. In: Bilezekian JP, Marcus R, Levine MA, eds. The parathyroids: basic and clinical concepts. New York: Raven Press; 591-646.
21. Ballard HS, Frame B, Hartsock LJ. 1964 Familial multiple endocrine adenoma-peptic ulcer complex. Medicine. 43:481-516.
22. Scheithauer BW, Laws Jr ER, Kovacs K, Horvath E, Randall RV, Carney JA. 1987 Pituitary adenomas of the multiple endocrine neoplasia type I syndrome. Semin Diag Pathol. 4:205-211.
23. McCarthy MI, Noonan K, Wass JAH, Monson JP. 1990 Familial acromegaly: studies in three families. Clin Endocrinol (Oxf). 32:719-728.
24. Yuasa H, Tokito S, Nakagaki H, Kitamura K. 1990 Familial pituitary adenoma: report of four cases from two unrelated families. Neurol Med Chir (Tokyo). 30:1016-1019.
25. Matsuno A, Teramoto A, Yamada S, et al. 1994 Gigantism in sibling unrelated to multiple endocrine neoplasia: case report. Neurosurgery. 35:952-956.
26. Tamburrano G, Jaffrain-Rea M-L, Grossi A, Lise A, Bulletta C. 1992 L'acromegalie familiale. Ann Endocrinol (Paris). 53:201-207.
27. Pestell RG, Alford FP, Best JD. 1989 Familial acromegaly. Acta Endocrinol (Copenh). 121:286-289.
28. Abbassioun K, Fatourehchi V, Amirjamshidi A, Meibodi NA. 1986 Familial acromegaly with pituitary adenoma. J Neurosurg. 64:510-512.
29. Jones MK, Evans PJ, Jones IR, Thomas JP. 1984 Familial acromegaly. Clin Endocrinol (Oxf). 20:355-358.
30. Kurisaka M, Takei Y, Tsubokawa T, Moriyasu N. 1981 Growth hormone-secreting pituitary adenoma in uniovular twin brothers: case report. Neurosurgery. 8:226-230.
31. Levin SR, Hofeldt FD, Becker N, Wilson CB, Seymour R, Forsham PH. 1974 Hypersomatotropism and acanthosis nigricans in two brothers. Arch Intern Med. 134:365-367.
32. Farid NR, Buehler S, Russell NA, Maroun FB, Allerdice P, Smyth HS. 1980 Prolactinomas in familial multiple endocrine neoplasia syndrome type I. Am J Med. 69:874-880.
33. Bear JC, Briones-Urbina R, Fahey JF, Farid NR. 1985 Variant multiple endocrine neoplasia I (MEN IBurin): further studies and non-linkage to HLA. Hum Hered. 35:15-20.
34. Hershon KS, Kelly WA, Shaw CM, Schwartz R, Bierman EL. 1983 Prolactionomas as part of the multiple endocrine neoplastic syndrome type 1. Am J Med. 74:713-720.
35. Burin) to chromosome 11q: evidence for a founder effect in patients from Newfoundland. Am J Hum Genet. 54:1060-1066.
36. Shepherd JJ. 1991 The natural history of multiple endocrine neoplasia type 1:highly uncommon or highly unrecognized? Arch Surg. 126:935-952.
37. Burgess JR, Shepherd JJ, Parameswaran V, Hoffman L, Greenaway TM. 1996 Somatotrophinomas in multiple endocrine neoplasia type 1: a review of clinical phenotype and insulin-like growth factor-1 levels in a large multiple endocrine neoplasia type 1 kindred. Am J Med. 100:544-547.
38. Larsson C, Shepherd J, Nakamura, et al. 1992 Predictive testing for multiple endocrine neoplasia type 1 using DNA polymorphisms. J Clin Invest 89:1344-1349.
39. Blind E, Schmidt-Gayk H, Scharla S, et al. 1988 Two-site assay of intact parathyroid hormone in the investigation of primary hyperparathyroidism and other disorders of calcium metabolism compared with a midregion assay. J Clin Endocrinol Metab. 67:353-360.
40. Skogseid B, Eriksson B, Lundqvist G, et al. 1991 Multiple endocrine neoplasia type 1: a 10-year prospective screening study in four kindreds. J Clin Endocrinol Metab. 73:281-287.
41. Juul A, Bang P, Hertel NT, et al. 1994 Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab. 78:744-752.
42. Blum WF, Ranke MB, Kietzmann K, Gauggel E, Zeisel HJ, Bierich JR. 1990 A specific radioimmunoassay for the growth hormone (GH)-dependent somatomedin-binding protein: its use for diagnosis of GH deficiency. J Clin Endocrinol Metab. 70:1292-1298.
43. Grinspoon S, Clemmons D, Swearlingen B, Klibanski A. 1995 Serum insulin-like growth factor-binding protein-3 levels in the diagnosis of acromegaly. J Clin Endocrinol Metab. 80:927-932.
44. Baxter RC. 1990 Circulating levels and molecular distribution of the acid-labile (alpha) subunit of the high molecular weight insulin-like growth factor-binding protein complex. J Clin Endocrinol Metab. 70:1347-1353.
45. Irie M, Tsushima T. 1972 Increase of serum growth hormone concentration following thyrotropin-releasing hormone injection in patients with acromegaly or gigantism. J Clin Endocrinol Metab. 35:97-98.
46. Hartman ML, Pincus SM, Johnson ML, et al. 1994 Enhanced basal and disorderly growth hormone (GH) secretion distinguish acromegalic from normal pulsatile GH release. J Clin Invest. 94:1277-1288.
47. Martha PM, Gorman KM, Blizzard RM, Rogol AD, Veldhuis JD. 1992 Endogenous growth hormone secretion and clearance rates in normal boys, as determined by deconvolution analysis: relationship to age, pubertal status, and body mass. J Clin Endocrinol Metab. 74:336-344.
48. Leung DW, Spencer SA, Cachianes G, et al. 1987 Growth hormone receptor and serum binding protein: purification, cloning and expression. Nature. 330:537-543.
49. Mercado M, Carlsson L, Vitangcol R, Baumann G. 1993 Growth hormone-binding protein determination in plasma: a comparison of immunofunctional and growth hormone-binding assays. J Clin Endocrinol Metab. 76:1291-1294.
50. Jan T, Shaw MA, Baumann G. 1991 Effects of growth hormone-binding proteins on serum growth hormone measurements. J Clin Endocrinol Metab. 72:387-391.
51. Daughaday WH, Starkey RH, Saltman S, Gavin III JR, Mills-Dunlap B, Heath-Monnig E. 1987 Characterization of serum growth hormone (GH) and insulin-like growth factor I in active acromegaly with minimal elevation of serum GH. J Clin Endocrinol Metab. 65:617-623.
52. Bistritzer T, Lovchik JC, Chalew SA, Kowarski AA. 1988 Growth without growth hormone: the "invisible" GH syndrome. Lancet. 1:321-323.
53. Campino C, Szecowka J, Lopez JM, Mulchahey J, Seron-Ferre M. 1992 Growth hormone (GH) receptor antibodies with GH-like activity occur spontaneously in acromegaly. J Clin Endocrinol Metab. 74:751-756.
54. Pagesy P, Li JY, Rentier-Delrue F, et al. 1990 Growth hormone and somatostatin gene expresson in pituitary adenomas with active acromegaly and minimal plasma growth hormone elevation. Acta Endocrinol (Copenh). 122:745-752.
55. Thorner MO, Perryman RL, Cronin MJ, et al. 1982 Somatotroph hyperplasia. J Clin Invest. 70:965-977.
56. s and stimulate adenylyl cyclase in human pituitary tumours. Nature. 340:692-696.
57. Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM. 1991 Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med. 325:1688-1695.
58. Levine MA. 1991 The McCune-Albright syndrome: the whys and wherefores of abnormal signal transduction. N Engl J Med. 324:1738-1740.
59. Hosoi E, Yokogoshi Y, Hosoi E, Yokoi K, Sano T, Saito S. 1992 A pituitary specific point mutation of codon 201 of the Gsα gene in a pituitary adenoma of a patient with multiple endocrine neoplasia (MEN) type 1. Endocrinol Jpn. 39:319-324.
60. Thakker RV, Pook MA, Wooding C, Boscaro M, Scanarini M, Clayton RN. 1993 Association of somatotrophinomas with loss of alleles on chromosome 11 and with gsp mutations. J Clin Invest. 91:2815-2821.
61. O'Halloran DJ, Shalet SM. 1994 A family pedigree exhibiting features of both multiple endocrine neoplasia type 1 and McCune-Albright syndromes. J Clin Endocrinol Metab. 78:523-525.